The addition of vancomycin to beta-lactam prophylaxis in ... trial product was purchased removed the commercial labels and placed a sheath over the vial. Placebo consisted of matching empty ...

The label-free detection of the antibiotic vancomycin binding to mucopeptides on cantilever arrays, with 10 nM sensitivity and at clinically relevant concentrations in blood serum, could lead to ...

Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective in treating people who have a specific type of inflammatory bowel ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Vancomycin always has been a problematic agent for treating patients with Staphylococcus infections because of its poor tissue penetration and slow bactericidal activity. In recent years, its use ...

Study: Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures ...

Daptomycin is a lipopeptide with bactericidal activity that acts on the cell membrane of enterococci and is often used off-label to treat patients infected with vancomycin-resistant enterococci.

Study: Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.

The results of this study revealed that implementation of a vancomycin nomogram into a CPOE system was associated with an increased percentage of patients with an initial optimal vancomycin regimen.

Vancomycin is the drug of choice for treating cellulitis, study suggests. ScienceDaily . Retrieved June 3, 2025 from www.sciencedaily.com / releases / 2010 / 10 / 101024122348.htm ...